NCT06482489Recruiting
Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
Comparing Prostate Cancer Screening Between Standardized 3T MRI Screening Protocol and Low-Field MRI in a Prospective Study
Source: ClinicalTrials.gov · Last updated 30 Oct 2026
Brief summary (registry, in English)
This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients with suspicious prostate lesions found on high-field MRI.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 74 (estimated)
- First submitted
- 25 Jun 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 31 May 2027
- Lead sponsor
- University of Lausanne Hospitals
- Diseases
- Prostate cancer
- NCT number
- NCT06482489
What you commit to
- Study type: Observational
- Planned participants: 74
- From 1 Nov 2024 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- MR Contraindications as listed in the MR Safety Screening form
- WP2: 0.55T Prostate MRI with patients with metallic implant(s)
Other illness
- Individuals with a history of prostate cancer
- Any condition making the patient unsuitable for the study
- Individuals with a history of prostate cancer.
- Any condition making the patient unsuitable for the study
Other
- WP1: 0.55T MRI Protocol Development
- Contraindications as per MD instructions
- Refusal to be notified in case of incidental finding on the examination
- WP3: 0.55T Prostate MRI with patients with suspicious lesion(s)
- Contraindications as per MD instructions
- Refusal to be notified in case of incidental finding on the examination
Who the study is looking for
- Work Package1 (WP): 0.55T MRI Protocol Development
- Healthy male volunteers aged 18 and above.
- Agree to be contacted for incidental findings
- Signed informed consent
- WP2: 0.55T Prostate MRI with patients with metallic implant(s)
- Adult men (≥18 y.o) with 3T MRI reported as sub-diagnostic due to metallic implants
- Signed informed Consent
- WP3: 0.55T Prostate MRI with patients with suspicious lesion(s)
- Adult men (≥18 y.o)
- PI-RADS 4/5 lesions detected on 3T MRI, schedules for targeted biopsy
- Signed informed consent
Age in the registry: 18 years to - · Sex: Male
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lausanne University Hospital Coordinator of this site? Confirm its status | Lausanne | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.